See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
08:05am, Tuesday, Aug 12, 2025
Zenas BioPharma funded into 2026 but burning cash; obexelimab trials pose binary risk
Zenas BioPharma, Inc. (NASDAQ: ZBIO) - quick read on what's happening inside The company is executing an expensive, accelerated clinical and pre-commercial build for its lead drug obexelimab while monetizing regional rights (Zai, Tenacia, BMS). Cash and liquid securities are healthy today, but bu...
Z
Read More